Clinical Trial Update: A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of neratinib in combination with trastuzumab in adults with advanced breast cancer completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• neratinib (neratinib)

Snippet

Sponsor: Puma Biotechnology, Inc. | Conditions: Advanced Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-04-13